Heron Therapeutics, Inc.
HRTX
$2.11
-$0.06-2.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.64M | 3.66M | -4.85M | -9.24M | -3.16M |
| Total Depreciation and Amortization | 551.00K | 581.00K | 581.00K | 641.00K | 689.00K |
| Total Amortization of Deferred Charges | 211.00K | 300.00K | 377.00K | 144.00K | 140.00K |
| Total Other Non-Cash Items | 2.20M | 2.02M | 3.01M | 7.27M | 2.91M |
| Change in Net Operating Assets | -14.46M | -18.34M | 4.25M | -3.42M | -10.09M |
| Cash from Operations | -8.87M | -11.78M | 3.37M | -4.60M | -9.52M |
| Capital Expenditure | -109.00K | -638.00K | -431.00K | -637.00K | -- |
| Sale of Property, Plant, and Equipment | 42.00K | 27.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.34M | 12.03M | 4.40M | 2.69M | 1.28M |
| Cash from Investing | 2.27M | 11.42M | 3.97M | 2.05M | 1.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 423.00K | 14.00K | 503.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.00K | -- | -- | -11.00K | 11.00K |
| Cash from Financing | 64.00K | 423.00K | 14.00K | 492.00K | 11.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.53M | 61.00K | 7.36M | -2.06M | -8.23M |